论文信息 - Final report: Phase I trial of imatinib mesylate, hydroxyurea, and vatalanib for patients with recurrent malignant glioma (MG) - 字舞流文

Final report: Phase I trial of imatinib mesylate, hydroxyurea, and vatalanib for patients with recurrent malignant glioma (MG)

H. Friedman | D. Reardon | J. Rich | M. Egorin | J. Kirkpatrick | A. Desjardins | J. Vredenburgh | S. Sathornsumetee | J. Quinn | S. Gururangan